Skip to main content

Table 2 Model estimated predictors of clinical recognition via diagnosis codes for chronic kidney disease (n = 206,036)

From: Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance

 

Odds Ratio

(95% Confidence Interval)

Stage of CKD identified in lab data (ref: Stage 1)a

 Stage 2

0.33 (0.25, 0.44)

 Stage 3

2.41 (1.81, 3.20)

 Stage 4

10.14 (7.58, 13.57)

 Stage 5

23.06 (16.09, 33.05)

Age (ref: < 65)

 Age 65–69

0.80 (0.75, 0.87)

 Age 70–74

0.73 (0.68, 0.78)

 Age 75–79

0.66 (0.62, 0.71)

 Age 80+

0.52 (0.49, 0.56)

Male (ref: Female)

1.62 (1.56, 1.68)

Race/Ethnicity (ref: Non-Hispanic white)

 Hispanic

1.61 (1.46, 1.76)

 Non-Hispanic black

1.93 (1.84, 2.03)

 Others

0.95 (0.83, 1.07)

Urbanicity (ref: Non-core area)

 Large Central Metro

1.16 (1.07, 1.25)

 Large Fringe Metro

1.24 (1.16, 1.33)

 Medium Metro

1.21 (1.13, 1.29)

 Small Metro

1.27 (1.17, 1.37)

 Micropolitan

1.38 (1.28, 1.49)

Chronic Conditions (ref: 0–1)

 2–3

1.24 (1.01, 1.25)

 4–5

1.31 (1.18, 1.46)

 6+

1.43 (1.29, 1.60)

Medicaid Enrolled (ref: No)

1.10 (1.04, 1.15)

Outpatient Visits in 2010 (ref: 0–6)

 7–11

1.36 (1.29, 1.43)

 12–18

1.55 (1.47, 1.64)

 19+

1.85 (1.74, 1.96)

Saw Nephrologist in 2010 (ref: No)

16.65 (15.99, 17.34)

  1. a CKD Stages: Stage 1 = estimated glomerular filtration rate (eGFR) ≥90 ml/min/1.73m2 and urine albumin-to-creatinine ratio (UACR) ≥30 mg/g; Stage 2 = eGFR 60–89; Stage 3 = eGFR 30–59; Stage 4 = eGFR 15–29; Stage 5 = eGFR < 15